Eli Lilly (United States)

Systematic literature review of machine learning methods used in the analysis of real-world data for patient-provider decision making

Alan Brnabic, Lisa M. Hess

2021 · 116 Zit.

Automation Opportunities in Pharmacovigilance: An Industry Survey

Rajesh Ghosh, Dieter Kempf, Angela Pufko et al.

2020 · 47 Zit.

Large Language Models and Their Applications in Drug Discovery and Development: A Primer

James Lu, Keunwoo Choi, Maksim Eremeev et al.

2025 · 18 Zit.

The role of the data coordinating center in the DIG trial

William O. Williford, Joseph F. Collins, Anne Horney et al.

2003 · 8 Zit.

Methods Used for the Applicability of Real-World Data Sources to Individual Patient Decision Making

Alan Brnabic, LM Hess, G Cuyun Carter et al.

2018 · 3 Zit.

Lessons learned from the DIG trial

Debra Egan, Nancy L. Geller, Salim Yusuf et al.

2003 · 2 Zit.

Clinical use of amyloid-positron emission tomography neuroimaging: Practical and bioethical considerations

Michael M. Witte, Norman L. Foster, Adam Fleisher et al.

2015 · 0 Zit.

Use of AI within COA linguistic validation and eCOA migration processes: analysis and good practice recommendations

S. McKown, Benjamin F. Arnold, Frederique Boucher et al.

2026 · 0 Zit.

Med-ICE: Enhancing Factual Accuracy in Medical AI through Autonomous Multi-Agent Consensus

Zhiyuan Chen, Rui Wu, Ye Liu et al.

2026 · 0 Zit.

Abstract 4360716: An Artificial Intelligence Model for Clinical Event Adjudication in Cardiovascular Clinical Trial

Hiya Banerjee, Pierluigi Tricoci, Min Jiang et al.

2025 · 0 Zit.